Drug-Resistant Tumor Mutations Turned into New Immunotherapy Targets
Researchers use drug-resistance mutations to guide new immunotherapy, offering hope for treatment-resistant tumors.
Stay informed, stay connected—news for amigos everywhere.
Researchers use drug-resistance mutations to guide new immunotherapy, offering hope for treatment-resistant tumors.
Over 500 health experts from China and the U.S. united in Beijing to tackle global health challenges, aiming to boost medical collaboration and innovation. Exciting breakthroughs ahead! 🚀
Israeli and U.S. scientists have developed an antibody treatment that boosts the immune system to fight cancer effectively, offering new hope against aggressive tumors like triple-negative breast cancer.
Chinese scientists discover a probiotic from traditional food that could prevent colon cancer by targeting tumor cells and improving gut health.
China’s mRNA vaccine for Epstein-Barr virus positive tumors has been approved for clinical trials! This innovative therapy could be a game-changer in cancer treatment. 🚀
A new study by Chinese researchers reveals how fat-loving gut microbes fueled by high-fat diets can promote cancer growth by releasing specific chemicals.
Chinese scientists develop an AI tool that predicts unknown tumor origins with remarkable accuracy, potentially transforming cancer diagnosis and treatment.